BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7676716)

  • 1. Aggressive surgery for pancreatic duct cell cancer: feasibility, validity, limitations.
    Takahashi S; Ogata Y; Miyazaki H; Maeda D; Murai S; Yamataka K; Tsuzuki T
    World J Surg; 1995; 19(4):653-9; discussion 660. PubMed ID: 7676716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical indication and significance of portal vein resection in biliary and pancreatic cancer.
    Tashiro S; Uchino R; Hiraoka T; Tsuji T; Kawamoto S; Saitoh N; Yamasaki K; Miyauchi Y
    Surgery; 1991 Apr; 109(4):481-7. PubMed ID: 1848949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined resection of the pancreas and portal vein for pancreatic cancer.
    Takahashi S; Ogata Y; Tsuzuki T
    Br J Surg; 1994 Aug; 81(8):1190-3. PubMed ID: 7953357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative morbidity and long-term survival after pancreaticoduodenectomy with superior mesenterico-portal vein resection.
    Riediger H; Makowiec F; Fischer E; Adam U; Hopt UT
    J Gastrointest Surg; 2006; 10(8):1106-15. PubMed ID: 16966029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of combined pancreas and portal vein resection in surgery for pancreatic adenocarcinoma.
    Aramaki M; Matsumoto T; Etoh T; Ishio T; Himeno Y; Sasaki A; Yada K; Kawano K; Kitano S
    Hepatogastroenterology; 2003; 50(49):263-6. PubMed ID: 12630036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of the depth of portal vein wall invasion after curative resection for pancreatic adenocarcinoma.
    Fukuda S; Oussoultzoglou E; Bachellier P; Rosso E; Nakano H; Audet M; Jaeck D
    Arch Surg; 2007 Feb; 142(2):172-9; discussion 180. PubMed ID: 17309969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival benefits of portal vein resection for pancreatic cancer.
    Nakagohri T; Kinoshita T; Konishi M; Inoue K; Takahashi S
    Am J Surg; 2003 Aug; 186(2):149-53. PubMed ID: 12885608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatectomy combined with superior mesenteric-portal vein resection: report of 32 cases.
    Zhou GW; Wu WD; Xiao WD; Li HW; Peng CH
    Hepatobiliary Pancreat Dis Int; 2005 Feb; 4(1):130-4. PubMed ID: 15730937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic adenocarcinoma with venous involvement: is up-front synchronous portal-superior mesenteric vein resection still justified? A survey of the Association Française de Chirurgie.
    Delpero JR; Boher JM; Sauvanet A; Le Treut YP; Sa-Cunha A; Mabrut JY; Chiche L; Turrini O; Bachellier P; Paye F
    Ann Surg Oncol; 2015; 22(6):1874-83. PubMed ID: 25665947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total pancreatectomy for ductal adenocarcinoma of the pancreas with special reference to resection of the portal vein and multicentric cancer.
    Launois B; Franci J; Bardaxoglou E; Ramee MP; Paul JL; Malledant Y; Campion JP
    World J Surg; 1993; 17(1):122-6; discussion 126-7. PubMed ID: 8383381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic carcinoma: reappraisal of surgical experiences in one Japanese university hospital.
    Yamaguchi K; Shimizu S; Yokohata K; Noshiro H; Chijiiwa K; Tanaka M
    Hepatogastroenterology; 1999; 46(30):3257-62. PubMed ID: 10626197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Standard surgery as part of the multidisciplinary treatment for pancreatic cancer].
    Fujii Y; Ueda M; Yoshida K; Matsuo K; Takeda K; Morioka D; Tanaka K; Endo I; Togo S; Shimada H
    Nihon Geka Gakkai Zasshi; 2006 Jul; 107(4):177-81. PubMed ID: 16878410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors.
    Conlon KC; Klimstra DS; Brennan MF
    Ann Surg; 1996 Mar; 223(3):273-9. PubMed ID: 8604907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Extensive radical surgery for carcinomas of the head of the pancreas].
    Miyazaki I; Nagakawa T; Ohta T
    Gan To Kagaku Ryoho; 1992 Dec; 19(14):2333-7. PubMed ID: 1463338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Debate: extended resection for pancreatic cancer; the affirmative case.
    Nakao A
    J Hepatobiliary Pancreat Surg; 2003; 10(1):57-60. PubMed ID: 12918458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Portal vein resection in patients undergoing pancreatoduodenectomy for carcinoma of the pancreatic head.
    Allema JH; Reinders ME; van Gulik TM; van Leeuwen DJ; de Wit LT; Verbeek PC; Gouma DJ
    Br J Surg; 1994 Nov; 81(11):1642-6. PubMed ID: 7827892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale of the so-called extended resection for pancreatic invasive ductal carcinoma.
    Imamura M; Hosotani R; Kogire M
    Digestion; 1999; 60 Suppl 1():126-9. PubMed ID: 10026446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between radiographic classification and pathological grade of portal vein wall invasion in pancreatic head cancer.
    Nakao A; Kanzaki A; Fujii T; Kodera Y; Yamada S; Sugimoto H; Nomoto S; Nakamura S; Morita S; Takeda S
    Ann Surg; 2012 Jan; 255(1):103-8. PubMed ID: 22156923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenterico-portal vein resection in patients with pancreatico-duodenal cancer is safe and may increase survival.
    Storkholm JH; Hansen CP
    Dan Med J; 2014 Jan; 61(1):A4757. PubMed ID: 24393587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional pancreatectomy: en bloc pancreatic, portal vein and lymph node resection.
    Fortner JG; Kim DK; Cubilla A; Turnbull A; Pahnke LD; Shils ME
    Ann Surg; 1977 Jul; 186(1):42-50. PubMed ID: 195543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.